Trevogrumab

From WikiMD's WELLNESSPEDIA

Trevogrumab
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number 1429201-24-0
PubChem
DrugBank
ChemSpider none
KEGG D11242


Trevogrumab (INN[1]) (REGN1033) is a human monoclonal antibody designed for the treatment of muscle atrophy due to orthopedic disuse and sarcopenia.

This drug was developed by Regeneron Pharmaceuticals, Inc.[2]

References[edit]

  1. World Health Organization."International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 113".WHO Drug Information.2015;29(2)Full text.
  2. Statement On A Nonproprietary Name Adopted By The USAN Council - Trevogrumab, American Medical Association.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.